| Secondary |
| Bipolar I Disorder |
24.9% |
| Product Used For Unknown Indication |
18.9% |
| Schizophrenia |
16.2% |
| Drug Use For Unknown Indication |
8.1% |
| Delirium |
6.8% |
| Epilepsy |
3.2% |
| Adjustment Disorder |
2.2% |
| Bronchopulmonary Aspergillosis |
2.2% |
| Gastritis |
2.2% |
| Parkinsonism |
1.9% |
| Psychotic Disorder |
1.9% |
| Depression |
1.6% |
| Sedative Therapy |
1.6% |
| Vaginitis Bacterial |
1.6% |
| Abnormal Behaviour |
1.4% |
| Agitation |
1.1% |
| Anaemia |
1.1% |
| Analgesic Therapy |
1.1% |
| Cardiac Failure |
1.1% |
| Convulsion |
1.1% |
|
| Tachycardia |
17.0% |
| Anaemia |
7.5% |
| Intra-uterine Death |
7.5% |
| Restless Legs Syndrome |
7.5% |
| Somnolence |
5.7% |
| Vaginitis Gardnerella |
5.7% |
| Vomiting |
5.7% |
| Anticonvulsant Drug Level Above Therapeutic |
3.8% |
| Hypotension |
3.8% |
| Neuroleptic Malignant Syndrome |
3.8% |
| Polydipsia |
3.8% |
| Rhabdomyolysis |
3.8% |
| Sleep-related Eating Disorder |
3.8% |
| Thrombocytopenia |
3.8% |
| Tremor |
3.8% |
| Urinary Tract Infection |
3.8% |
| Water Intoxication |
3.8% |
| Bradycardia |
1.9% |
| Cholestasis |
1.9% |
| Convulsion |
1.9% |
|
| Concomitant |
| Schizophrenia |
28.7% |
| Depression |
14.6% |
| Product Used For Unknown Indication |
8.8% |
| Obsessive-compulsive Disorder |
6.6% |
| Psychotic Disorder |
4.3% |
| Epilepsy |
3.9% |
| Insomnia |
3.4% |
| Drug Use For Unknown Indication |
3.3% |
| Hiv Infection |
3.3% |
| Restlessness |
3.2% |
| Bipolar I Disorder |
2.7% |
| Cerebral Palsy |
2.5% |
| Mental Retardation Severity Unspecified |
2.5% |
| Smoking Cessation Therapy |
2.4% |
| Asthma |
2.1% |
| Bipolar Disorder |
2.0% |
| Sedation |
1.7% |
| Dementia Alzheimer's Type |
1.5% |
| Diabetes Mellitus |
1.4% |
| Hypertension |
1.3% |
|
| Weight Increased |
24.3% |
| Diabetes Mellitus |
15.5% |
| Crying |
5.8% |
| Pseudoepitheliomatous Hyperplasia |
5.8% |
| White Blood Cell Count Decreased |
4.9% |
| Hepatic Function Abnormal |
3.9% |
| Pyrexia |
3.9% |
| Somnolence |
3.9% |
| Cardiac Failure |
2.9% |
| Dysgeusia |
2.9% |
| Dyspnoea |
2.9% |
| Generalised Erythema |
2.9% |
| Rhabdomyolysis |
2.9% |
| Sepsis |
2.9% |
| Skin Exfoliation |
2.9% |
| Tremor |
2.9% |
| Vomiting |
2.9% |
| Depressed Level Of Consciousness |
1.9% |
| Fear |
1.9% |
| Feeling Guilty |
1.9% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
|
